Skip to main navigation Skip to search Skip to main content

Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 4: Functionalization of the benzopyran A-ring

  • Bryan H. Norman
  • , Timothy I. Richardson
  • , Jeffrey A. Dodge
  • , Lance A. Pfeifer
  • , Gregory L. Durst
  • , Yong Wang
  • , Jim D. Durbin
  • , Venkatesh Krishnan
  • , Sean R. Dinn
  • , Shengquan Liu
  • , John E. Reilly
  • , Kendal T. Ryter

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Benzopyrans are selective estrogen receptor (ER) β agonists (SERBAs), which bind the ER receptor subtypes α and β in opposite orientations. We have used structure based drug design to show that this unique phenomena can be exploited via substitution at the 8-position of the benzopyran A-ring to disrupt binding to ERα, thus improving ERβ subtype selectivity. X-ray cocrystal structures with ERα and ERβ are supportive of this approach to improve selectivity in this structural class.

Original languageEnglish
Pages (from-to)5082-5085
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number18
DOIs
StatePublished - Sep 15 2007

Keywords

  • Crystallography
  • Estrogen receptor β
  • Prostate

Fingerprint

Dive into the research topics of 'Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 4: Functionalization of the benzopyran A-ring'. Together they form a unique fingerprint.

Cite this